Liberia's HIV cases have increased to approximately 36,000 people, up from 34,000 last year, according to new UNAIDS Spectrum 2025 data released Thursday by the National AIDS Commission (NAC). The ...
Monrovia- The National AIDS Commission (NAC) has raised alarm over a worrying rise in HIV infections in Liberia. Tumu-jaheim ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Clinical Trials Arena on MSN
MSD’s once-daily HIV pill non-inferior to Biktarvy in Phase III trial
MSD announced the data just days after Gilead also touted success with a once-daily antiretroviral therapy (ART).
To mark World AIDS Day, the Institute for Contemporary Arts will screen our film tackling the collapse of USAID funding ...
Indian River County recorded the highest rate of new cases on the Treasure Coast, with 14 per 100,000 people diagnosed with ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
The Maldives has become the first country in the world to attain triple elimination of mother-to-child transmission of ...
Deniz Gökengin thinks colleagues view her as “a very serious, hardworking, meticulous, control-freak type of person”. But she ...
The investigational oral therapy combines doravirine, a non-nucleoside reverse transcriptase inhibitor, with islatravir, a nucleoside reverse transcriptase translocation inhibitor, in a single tablet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback